COVID-19 and Lung Cavitation: A Clue to Pathogenesis?

HCA Healthc J Med. 2022 Aug 29;3(4):253-256. doi: 10.36518/2689-0216.1361. eCollection 2022.

Abstract

Description Lung cavitation as a complication of COVID-19 is rare. A 56-year-old male presented with lung cavitation, small volume hemoptysis, and violaceous discoloration of the right great toe, 5 weeks after diagnosis with COVID-19 pneumonia. The digital changes were consistent with previously described microvascular changes called "COVID toe." CT angiography of the chest was negative for pulmonary embolism but showed a 2.5 x 3.1 x 2.2 cm cavitation within the right lung. Extensive evaluation for commonly implicated infectious and autoimmune causes was negative. We concluded that the cavitary lung lesions were likely a complication of COVID-19 pneumonia and may implicate microangiopathy as an important component of pathogenesis. This case highlights a rare complication of COVID-19 of which clinicians should be aware.

Keywords: COVID-19/complications; COVID-19/diagnosis; SARS-CoV-2; lung cavitation; lung diseases; male; thoracic radiography; viral pneumonia.

Publication types

  • Case Reports

Grants and funding

This research was supported (in whole or in part) by HCA Healthcare and/or an HCA Healthcare affiliated entity.